Palisade Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	132.63	133.39	9.82	12.43	12.38	10.5
Cash & Short-Term Investments	132.63	133.39	9.82	12.43	12.38	10.5
Cash Growth	1734.41%	1258.16%	-21.00%	0.40%	17.99%	1371.95%
Other Current Assets	0.62	0.84	0.67	0.9	2.35	1.01
Total Current Assets	133.24	134.22	10.49	13.33	14.73	11.51
Net Property, Plant & Equipment	-	-	0.09	0.21	0.31	0.11
Other Long-Term Assets	0.07	0.12	0.3	0.52	0.72	0.89
Total Assets	133.32	134.34	10.88	14.05	15.76	12.51
Accounts Payable	2.7	0.77	1.11	0.7	1.76	1.32
Accrued Expenses	2.92	3.49	1.96	1.61	1.06	0.97
Short-Term Debt	-	0.07	0.08	0.16	0.09	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.09
Current Portion of Leases	-	-	0.09	0.12	0.11	0.11
Other Current Liabilities	-	0.31	-	-	-	-
Total Current Liabilities	5.62	4.64	3.24	2.59	3.01	2.5
Long-Term Leases	-	-	-	0.09	0.21	-
Other Long-Term Liabilities	0.33	0.33	0.15	0.06	0.06	2.65
Total Long-Term Liabilities	0.33	0.33	0.15	0.15	0.27	2.65
Total Liabilities	5.95	4.96	3.39	2.74	3.28	5.15
Preferred Stock	0	0	0	0	0	0
Common Stock	-	1.59	0.03	0.01	0.03	0
Additional Paid-in Capital	288.01	280.51	143.41	132.81	121.64	102
Retained Earnings	-162.33	-152.73	-135.94	-121.51	-109.19	-94.64
Total Common Shareholders' Equity	127.36	129.38	7.49	11.31	12.48	7.37
Shareholders' Equity	127.36	129.38	7.49	11.31	12.48	7.37
Total Liabilities & Equity	133.32	134.34	10.88	14.05	15.76	12.51
Total Debt	-	0.07	0.17	0.37	0.4	0.2
Net Cash (Debt)	132.63	133.31	9.65	12.06	11.98	10.3
Net Cash Growth	-0.52%	1281.21%	-19.99%	0.70%	16.35%	-
Net Cash Per Share	1.24	2.40	6.81	12.21	204.12	826.07
Book Value	127.36	129.38	7.49	11.31	12.48	7.37
Book Value Per Share	1.19	2.32	5.29	11.45	212.63	590.91
Tangible Book Value	127.36	129.38	7.49	11.31	12.48	7.37
Tangible Book Value Per Share	1.19	2.32	5.29	11.45	212.63	590.91

SEC Filings: 10-K · 10-Q